chr6-73696229-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_133493.5(CD109):c.14C>A(p.Pro5Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000359 in 1,392,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_133493.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD109 | NM_133493.5 | c.14C>A | p.Pro5Gln | missense_variant | 1/33 | ENST00000287097.6 | NP_598000.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD109 | ENST00000287097.6 | c.14C>A | p.Pro5Gln | missense_variant | 1/33 | 1 | NM_133493.5 | ENSP00000287097.4 | ||
CD109 | ENST00000437994.6 | c.14C>A | p.Pro5Gln | missense_variant | 1/33 | 1 | ENSP00000388062.2 | |||
CD109 | ENST00000422508.6 | c.14C>A | p.Pro5Gln | missense_variant | 1/32 | 1 | ENSP00000404475.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000359 AC: 5AN: 1392334Hom.: 0 Cov.: 31 AF XY: 0.00000145 AC XY: 1AN XY: 687808
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The c.14C>A (p.P5Q) alteration is located in exon 1 (coding exon 1) of the CD109 gene. This alteration results from a C to A substitution at nucleotide position 14, causing the proline (P) at amino acid position 5 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at